S-23
CAS No. 1010396-29-8
S-23 ( S 23; S23; (S)-3-(4-chloro-3-fluorophenoxy)-N-(4-cyano-3-(trifluoromethyl)phenyl)-2-hydroxy-2-methylpropanamide )
Catalog No. M27332 CAS No. 1010396-29-8
S-23 is an oral selective androgen receptor modulator (SARM) with a Ki of 1.7 nM. S-23 increases prostate, seminal vesicle, and levator ani muscle weights in castrated rats.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 35 | Get Quote |
|
10MG | 58 | Get Quote |
|
25MG | 115 | Get Quote |
|
50MG | 177 | Get Quote |
|
100MG | 290 | Get Quote |
|
200MG | 430 | Get Quote |
|
500MG | 695 | Get Quote |
|
1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameS-23
-
NoteResearch use only, not for human use.
-
Brief DescriptionS-23 is an oral selective androgen receptor modulator (SARM) with a Ki of 1.7 nM. S-23 increases prostate, seminal vesicle, and levator ani muscle weights in castrated rats.
-
DescriptionS-23 is an oral selective androgen receptor modulator (SARM) with a Ki of 1.7 nM. S-23 increases prostate, seminal vesicle, and levator ani muscle weights in castrated rats.(In Vitro):Administration of 10 nM S-23 induces AR-mediated transcriptional activation in CV-1 cells .(In Vivo):Administration of S-23 to castrated animals increases the weights of the androgen-dependent organ dose-dependently with the ED50s of S-23 in the prostate and levator ani muscle of 0.43 and 0.079 mg/d, respectively.
-
SynonymsS 23; S23; (S)-3-(4-chloro-3-fluorophenoxy)-N-(4-cyano-3-(trifluoromethyl)phenyl)-2-hydroxy-2-methylpropanamide
-
PathwayEndocrinology/Hormones
-
TargetAndrogen Receptor (AR)
-
RecptorPDE3
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1010396-29-8
-
Formula Weight416.8
-
Molecular FormulaC18H13ClF4N2O3
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESC[C@](O)(COc1ccc(Cl)c(F)c1)C(=O)Nc1ccc(C#N)c(c1)C(F)(F)F
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Murray KJ, et al. The effects of siguazodan, a selective phosphodiesterase inhibitor, on human platelet function. Br J Pharmacol. 1990 Mar;99(3):612-6.
molnova catalog
related products
-
JNJ63576253
JNJ-63576253 is a Clinical Stage Androgen Receptor Antagonist for F877L Mutant and Wild-Type Castration-Resistant Prostate Cancer (mCRPC).
-
Flutamide
Flutamide is an antiandrogen drug, with its active metablolite binding at androgen receptor.
-
ARV-110
ARV-110 is an oral degrader of androgen receptor PROTAC for prostate cancer treatment.